Literatur
- 1
Angeja B G, Grossman W.
Evaluation and management of diastolic heart failure.
Circulation.
2003;
107
659-663
- 2
Arbab-Zadeh A, Dijk E, Prasad A. et al .
Effect of aging and physical activity on left ventricular compliance.
Circulation.
2004;
110
1799-1805
- 3
Aurigemma G P, Gaasch W H.
Diastolic heart failure.
N Engl J Med.
2004;
351
1097-1105
- 4
Aurigemma G P, Gottdiener J S, Shemanski L. et al .
Predictive value of systolic and diastolic dysfunction for incident congestive heart
failure in the elderly: the Cardiovascular Health Study.
J Am Coll Cardiol.
2001;
37
1042-1048
- 5
Baicu C F, Zile R, Aurigemma G P, Gaasch W H.
Left ventricular systolic performance, function, and contractility in patients with
diastolic heart failure.
Circulation.
2005;
111
2306-2312
- 6
Bella J N, Palmieri V, Roman M E. et al .
Mitral ration of peak early to late diastolic ventricular filling velocity as a predictor
of mortality in middle-aged and elderly adults. The Strong Heart Study.
Circulation.
2002;
105
1928-1933
- 7
Borbély A, vanderVelden J, Papp Z. et al .
Cardiomyocyte stiffness in diastolic heart failure.
Circulation.
2005;
111
774-781
- 8
Cleland J GF, Swedberg K, Follath F. et al .
The EuroHeart Failure survey programme - a survey on the quality of care among patients
with heart failure in Europe.
Europ Heart J.
2003;
24
442-463
- 9
European Study Group on Diastolic Heart Failure .
How to diagnose diastolic heart failure.
Eur Heart J.
1998;
19
990-1003
- 10
Fukuta H, Sane D C, Brucks S, Little W C.
Statin therapy may be associated with lower mortality in patients with diastolic heart
failure. A preliminary report.
Circulation.
2005;
112
357-363
- 11
Haass M.
Biomarker bei Herzinsuffizienz.
Kardiologie up2date.
2005;
1
23-44
- 12
Hasenfuß G, Pieske B.
Calcium cycling in congestive heart failure.
J Mol Cell Cardiol.
2002;
34
951-969
- 13
Kawaguchi M, Hay I, Fetics B, Kass D A.
Combined ventricular systolic and arterial stiffening in patients with heart failure
and preserved ejection fraction.
Circulation.
2003;
107
714-720
- 14
Kitzman D W, Higginbotham M B, Cobb F R. et al .
Exercise intolerance in patients with heart failure and preserved left ventricular
systolic function: failure of the Frank-Starling mechanism.
Am J Coll Cardiol.
1991;
17
1065-1072
- 15
Lubien D, DeMaria A, Krishnaswamy P. et al .
Utility of B-natriuretic peptide in detecting diastolic dysfunction.
Circulation.
2002;
105
451-460
- 16
Ommen S R, Nishimura R A.
A clinical approach to the assessement of left ventricular diastolic function by doppler
echocardiography: Update 2003.
Heart.
2003;
89 Suppl. III
18-23
- 17
Redfield M M, Jacobsen S J, Burnett J C. et al .
Burden of systolic and diastolic ventricular dysfunction in the community.
JAMA.
2004;
289
194-202
- 18
Redfield M M, Rodeheffer R J, Jacobsen S J. et al .
Plasma Brain Natriuretic Peptide to detect preclinical ventricular systolic or diastolic
dysfunnction.
Circulation.
2004;
109
3176-3181
- 19
Schmidt A G, Pieske B.
Diastolische Herzinsuffizienz.
Dtsch Med Wochenschr.
2005;
130
1207-1218
- 20
Smith G L. et al .
Outcomes in heart failure patients with preserved ejection fraction.
J Am Col Cardiol.
2003;
41
1510-1518
- 21
Sueta C A, Russo A, Schenk A. et al .
Effect of angiotensin converting inhibitor or angiotensin receptor blocker on one
year survival in patients ≥ 65 years hospitalized with a left ventricular ejection
fraction ≥ 50 %.
Am J Cardiol.
2003;
91
363-365
- 22
Vasan R, Benjamin E J, Levy D.
Prevalence, clinical features, and prognosis of diastolic heart failure: an epidemiological
perspective.
J A Coll Cardiol.
1995;
26
1565-1574
- 23
Vasan R D, Levy D.
Defining diastolic heart failure. A call for standardized diagnostic criteria.
Circulation.
2000;
101
2118-2121
- 24
Wachter R, Pieske B.
Restriktive Kardiomyopathie.
Herz.
2005;
30
558-564
- 25
Wolf-Maier K, Cooper R S, Kramer H. et al .
Hypertension treatment and control in five European countries, Canada, and the United
States.
Hypertension.
2004;
43
10-17
- 26
Yusuf S, Pfeffer M A, Swedberg K. et al .
Effects of Candesartan in patients with chronic heart failure and preserved left-ventricular
ejection fraction: the CHARM-Preserved trial.
Lancet.
2003;
362
777-781
- 27
Zieman S J, Kass D A.
Advanced glycation endproduct crosslinking in the cardiovascular system. Potential
therapeutic target for cardiovascular disease.
Drugs.
2004;
64
459-470
- 28
Zile M R, Baicu C F, Gaasch W.
Diastolic heart failure - abnormalities in active relxation and passive stiffness
of the left ventricle.
N Engl J Med.
2004;
350
1953-1959
- 29
Zile M R, Brutsaert D L.
New concepts in diastolic dysfunctionand diastolic heart failure. Part II. Causal
mechanisms and treatment.
Circulation.
2002;
105
1503-1508
Prof. Dr. med. Burkert Pieske
Abteilung Kardiologie und Pneumologie · Universität Göttingen
Robert-Koch-Str. 40 · 37075 Göttingen
eMail: pieske@med.uni-goettingen.de
